| 000 | 01838 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516031203.0 | ||
| 264 | 0 | _c20111227 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-011-1613-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBapiro, Tashinga E | |
| 245 | 0 | 0 |
_aA novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cNov 2011 |
||
| 300 |
_a1243-53 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 | _aCalibration |
| 650 | 0 | 4 |
_aCytidine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFloxuridine _xanalogs & derivatives |
| 650 | 0 | 4 | _aFluorine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aReference Standards |
| 650 | 0 | 4 |
_aTandem Mass Spectrometry _xmethods |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aRichards, Frances M | |
| 700 | 1 | _aGoldgraben, Mae A | |
| 700 | 1 | _aOlive, Kenneth P | |
| 700 | 1 | _aMadhu, Basetti | |
| 700 | 1 | _aFrese, Kristopher K | |
| 700 | 1 | _aCook, Natalie | |
| 700 | 1 | _aJacobetz, Michael A | |
| 700 | 1 | _aSmith, Donna-Michelle | |
| 700 | 1 | _aTuveson, David A | |
| 700 | 1 | _aGriffiths, John R | |
| 700 | 1 | _aJodrell, Duncan I | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 68 _gno. 5 _gp. 1243-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-011-1613-0 _zAvailable from publisher's website |
| 999 |
_c20701315 _d20701315 |
||